Toxicology reports confirmed the presence of citalopram, an SSRI antidepressant, in the system of former Philippine public official Maria Catalina Cabral, who died on December 19, 2025, following a fall in Benguet. Authorities have stated the death is being treated as suicide, with no evidence of foul play, and the investigation remains ongoing.

In response to public discussion, the Philippine Psychiatric Association cautioned against linking antidepressants to suicide, emphasizing untreated depression as a risk factor and noting that SSRIs are considered safe when appropriately prescribed and monitored.

MISSD supports informed consent and transparency about known medication risks so that healthcare consumers, providers, and family members can be better informed prior to prescription. All SSRIs carry a black box warning from the U.S. Food and Drug Administration for increased suicidal thoughts and behavior, particularly during treatment initiation or dose changes. Akathisia—a severe, medication-induced state of inner agitation—remains underrecognized and can contribute to suicidal crises.

We extend our condolences to Ms. Cabral’s family. Learn more at missd.co and read the full article at https://www.philstar.com/headlines/2025/12/30/2497741/psychiatrists-warn-against-linking-antidepressants-suicide.